Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Nov. 01, 2014	Nov. 02, 2013
Operating activities:
Net income	$ 67,718	$ 97,750
Adjustments to reconcile net income to net cash provided by/(used for) operating activities:
Deferred income taxes	(5,547)	8,217
Depreciation and amortization	83,097	78,690
Loss on disposal and write-down of property and equipment	2,302	3,584
Stock-based compensation	9,621	11,621
Non-cash interest and other non-cash items	(1,468)	(470)
Tax benefit from exercise/vesting of stock awards	1,131	1,601
Changes in assets and liabilities:
Accounts receivable	(9,915)	(18,799)
Merchandise inventories	(91,770)	(85,547)
Prepaid expenses and other current assets	(2,670)	(1,352)
Refundable income taxes	(1,383)	1,836
Other non-current assets	1,384	401
Other non-current liabilities	(7,499)	13,468
Accounts payable, accrued expenses and other current liabilities	(10,020)	(6,210)
Net cash provided by/(used for) operating activities	34,981	104,790
Investing activities:
Purchases of marketable securities	(2,362)	(3,215)
Sales of marketable securities	1,734	574
Purchases of property and equipment	(84,902)	(103,607)
Other, net	(147)	813
Net cash used for investing activities	(85,677)	(105,435)
Financing activities:
Proceeds from the issuance of common stock pursuant to the Associate Discount Stock Purchase Plan	1,666	1,660
Proceeds from exercise of stock options	13,935	5,536
Excess tax benefits from stock-based compensation	1,802	1,860
Repurchases of common and restricted stock	(54,582)	(53,854)
Repayments of fixed asset financing and capital lease obligations	(2,562)	(1,565)
Proceeds from fixed asset financing	0	4,317
Change in trade payable program obligation, net	(1,502)	(5,296)
Net cash provided by/(used for) financing activities	(41,243)	(47,342)
Effect of exchange rate on cash and cash equivalents	(7)	(332)
Net increase/(decrease) in cash and cash equivalents	(91,946)	(48,319)
Cash and cash equivalents, beginning of period	201,707	167,011
Cash and cash equivalents, end of period	$ 109,761	$ 118,692